Literature DB >> 25403663

Evolution and transmission patterns of extensively drug-resistant tuberculosis in China.

Feifei Wang1, Lingyun Shao2, Xiaoping Fan2, Yaojie Shen2, Ni Diao2, Jialin Jin2, Feng Sun2, Jing Wu2, Jiazhen Chen2, Xinhua Weng2, Xunjia Cheng3, Ying Zhang4, Wenhong Zhang5.   

Abstract

The emergence and transmission of extensively drug-resistant tuberculosis (XDR-TB) pose an increasing threat to global TB control. This study aimed to identify the patterns of evolution and transmission dynamics of XDR-TB in populations in a region of China where TB is highly endemic. We analyzed a total of 95 XDR-TB isolates collected from 2003 to 2009 in Chongqing, China. Eight drug resistance genes covering 7 drugs that define XDR-TB were amplified by PCR followed by DNA sequencing. Variable-number tandem repeat 16-locus (VNTR-16) genotyping and genotypic drug resistance profiles were used to determine the evolution or transmission patterns of XDR-TB strains. Our results indicated that the Beijing genotype was predominant (85/95 [89.5%]) in XDR-TB strains, and as many as 40.0% (38/95) of the isolates were distributed into 6 clusters based on VNTR-16 genotyping and drug resistance mutation profiles. All isolates of each cluster harbored as many as six identical resistance mutations in the drug resistance genes rpoB, katG, inhA promoter, embB, rpsL, and gidB. Among the nine cases with continuous isolates from multidrug-resistant (MDR) to XDR-TB, 4 cases represented acquired drug resistance, 4 cases were caused by transmission, and 1 case was due to exogenous superinfection. The XDR-TB epidemic in China is mainly caused by a high degree of clonal transmission, but evolution from MDR to XDR and even superinfection with a new XDR strain can also occur.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25403663      PMCID: PMC4335892          DOI: 10.1128/AAC.03504-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-03-24       Impact factor: 17.586

2.  Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-08-30       Impact factor: 17.586

3.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain.

Authors:  J V Rullán; D Herrera; R Cano; V Moreno; P Godoy; E F Peiró; J Castell; C Ibañez; A Ortega; L S Agudo; F Pozo
Journal:  Emerg Infect Dis       Date:  1996 Apr-Jun       Impact factor: 6.883

5.  Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.

Authors:  A Laszlo; M Rahman; M Espinal; M Raviglione
Journal:  Int J Tuberc Lung Dis       Date:  2002-09       Impact factor: 2.373

6.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

7.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.

Authors:  B R Edlin; J I Tokars; M H Grieco; J T Crawford; J Williams; E M Sordillo; K R Ong; J O Kilburn; S W Dooley; K G Castro
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

8.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods.

Authors:  P M Small; P C Hopewell; S P Singh; A Paz; J Parsonnet; D C Ruston; G F Schecter; C L Daley; G K Schoolnik
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

9.  [Study on the molecular epidemiology of Mycobacterium tuberculosis in Shanghai].

Authors:  Jian Mei; Xin Shen; Jia Zha; Bin Sun; Mei Shen; Guo-miao Shen; Qian Gao
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2005-09

10.  Evolution and transmission of drug-resistant tuberculosis in a Russian population.

Authors:  Nicola Casali; Vladyslav Nikolayevskyy; Yanina Balabanova; Simon R Harris; Olga Ignatyeva; Irina Kontsevaya; Jukka Corander; Josephine Bryant; Julian Parkhill; Sergey Nejentsev; Rolf D Horstmann; Timothy Brown; Francis Drobniewski
Journal:  Nat Genet       Date:  2014-01-26       Impact factor: 38.330

View more
  6 in total

Review 1.  Deciphering Within-Host Microevolution of Mycobacterium tuberculosis through Whole-Genome Sequencing: the Phenotypic Impact and Way Forward.

Authors:  A Van Rie; R M Warren; S D Ley; M de Vos
Journal:  Microbiol Mol Biol Rev       Date:  2019-03-27       Impact factor: 11.056

2.  Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.

Authors:  Angela M Starks; Enrique Avilés; Daniela M Cirillo; Claudia M Denkinger; David L Dolinger; Claudia Emerson; Jim Gallarda; Debra Hanna; Peter S Kim; Richard Liwski; Paolo Miotto; Marco Schito; Matteo Zignol
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

3.  Severe Clinical Outcomes of Tuberculosis in Kharkiv Region, Ukraine, Are Associated with Beijing Strains of Mycobacterium tuberculosis.

Authors:  Olha Konstantynovska; Mariia Rekrotchuk; Ivan Hrek; Anton Rohozhyn; Nataliia Rudova; Petro Poteiko; Anton Gerilovych; Eric Bortz; Oleksii Solodiankin
Journal:  Pathogens       Date:  2019-06-10

4.  Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis1.

Authors:  Hongbo Shen; Enzhuo Yang; Ming Guo; Rui Yang; Guixian Huang; Ying Peng; Wei Sha; Feifei Wang; Ling Shen
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

5.  Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai.

Authors:  Yong Chen; Zhengan Yuan; Xin Shen; Jie Wu; Zheyuan Wu; Biao Xu
Journal:  Biomed Res Int       Date:  2016-08-29       Impact factor: 3.411

Review 6.  The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa.

Authors:  Prince Asare; Adwoa Asante-Poku; Stephen Osei-Wusu; Isaac Darko Otchere; Dorothy Yeboah-Manu
Journal:  Front Public Health       Date:  2021-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.